Agilent Technologies (NYSE:A) Releases FY 2025 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of 5.540-5.610 for the period, compared to the consensus estimate of 5.660. The company issued revenue guidance of $6.8 billion-$6.9 billion, compared to the consensus revenue estimate of $6.8 billion. Agilent Technologies also updated its FY25 guidance to $5.54-5.61 EPS.

Agilent Technologies Stock Up 2.8 %

A opened at $138.11 on Thursday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The company’s 50-day moving average is $137.72 and its 200 day moving average is $137.43. Agilent Technologies has a fifty-two week low of $124.10 and a fifty-two week high of $155.35. The firm has a market capitalization of $39.68 billion, a P/E ratio of 28.65, a PEG ratio of 5.91 and a beta of 1.07.

Agilent Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be given a dividend of $0.248 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date is Tuesday, December 31st. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.54%.

Analysts Set New Price Targets

Several brokerages have commented on A. Wells Fargo & Company began coverage on shares of Agilent Technologies in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 price objective on the stock. StockNews.com downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday. TD Cowen boosted their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Evercore ISI boosted their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. Finally, Sanford C. Bernstein cut their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday. One analyst has rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, Agilent Technologies has a consensus rating of “Hold” and an average price target of $143.40.

Insiders Place Their Bets

In other news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This represents a 19.98 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.33% of the company’s stock.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.